Oxidative stress and neurodegeneration: Where are we now?

Journal of Neurochemistry

Volumn 97, Issue 6, 2006, Pages 1634-1658

  Halliwell, Barry ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Free radical; Hydroxyl radical; Proteasome; Protein aggregation; Reactive oxygen species; Superoxide

Indexed keywords

ANTIOXIDANT; DNA; GLUTATHIONE; HEMOGLOBIN; LIPID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; AUTOOXIDATION; BEHAVIOR MODIFICATION; BLOOD BRAIN BARRIER; BRAIN MITOCHONDRION; BRAIN PROTECTION; CELL DAMAGE; DECOMPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA STRAND; ELECTRON TRANSPORT; GLUTATHIONE METABOLISM; HUMAN; HUNTINGTON CHOREA; INBORN ERROR OF METABOLISM; LEWY BODY; LIFESTYLE; LIPID PEROXIDATION; MITOCHONDRION SWELLING; NERVE DEGENERATION; NEUROTOXICITY; OXIDATIVE STRESS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SUBSTANTIA NIGRA; UBIQUITINATION;

ANIMALS; ANTIOXIDANTS; ENERGY METABOLISM; FREE RADICALS; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33745013111     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03907.x     Document Type: Review

References (211)

1. Abramov A. Y. Duchen M. R. 2005 The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid β peptides. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 2309 2314.
2. Aksenov M. Y. Aksenova M. V. Carney J. M. Butterfield D. A. 1997 Oxidative modification of glutamine synthetase by amyloid β peptide. Free Radic. Res. 27, 267 281.
3. Alayash A. I. 2004 Oxygen therapeutics: can we tame haemoglobin? Nat. Rev. Drug Discov. 3, 152 159.
4. Alvarez B. Radi R. 2003 Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25, 295 311.
5. Araki T. Sasaki Y. Milbrandt J. 2004 Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010 1013.
6. Aruoma O. I. Laughton M. J. Halliwell B. 1989 Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochem. J. 264, 863 869.
7. Asaeda M. Sakamoto M. Kurosaki M. Tabuchi S. Kamitani H. Yokota M. Watanabe T. 2005 A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm. Neurosci. Lett. 373, 222 225.
8. Augusto O. Bonini M. G. Amanso A. M. Linares E. Santos C. C. De Menezes S. L. 2002 Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic. Biol. Med. 32, 841 859.
9. Babcock G. T. 1999 How oxygen is activated and reduced in respiration. Proc. Natl Acad. Sci. USA 96, 12 971 12 973.
10. Back S. A. Luo N. L. Mallinson R. A. et al. 2005 Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann. Neurol. 58, 108 120.
11. Barnham K. J. Masters C. L. Bush A. I. 2004 Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205 214.
12. Beal M. F. Shults C. W. 2003 Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease. Biofactors 18, 153 161.
13. Bence N. F. Sampat R. M. Kopito R. R. 2001 Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552 1555.
14. Blacker D. 2005 Mild cognitive impairment - no benefit from vitamin E, little from donepezil. N. Engl. J. Med. 352, 2439 2441.
15. von Bohlen und Halbach O. Schober A. Krieglstein K. 2004 Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog. Neurobiol. 73, 151 177.
16. Bota D. A. Davies K. J. 2002 Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell Biol. 4, 674 680.
17. Bredt D. S. 1999 Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31, 577 596.
18. Brigelius-Flohe R. 1999 Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 27, 951 965.
19. Burdo J. R. Connor J. R. 2003 Brain iron uptake and homeostatic mechanisms: an overview. Biometals 16, 63 75.
20. Burmester T. Hankeln T. 2004 Neuroglobin: a respiratory protein of the nervous system. News Physiol. Sci. 19, 110 113.
21. Calabrese V. Lodi R. Tonon C. D'Agata V. Sapienza M. Scapagnini G. Mangiameli A. Pennisi G. Stella A. M. Butterfield D. A. 2005 Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 233, 145 162.
22. Capasso M. Jeng J. M. Malavolta M. Mocchegiani E. Sensi S. L. 2005 Zinc dyshomeostasis: a key modulator of neuronal injury. J. Alzheimers Dis. 8, 93 108.
23. Carrasco J. Penkowa M. Giralt M. Camats J. Molinero A. Campbell I. L. Palmiter R. D. Hidalgo J. 2003 Role of metallothionein-III following central nervous system damage. Neurobiol. Dis. 13, 22 36.
24. Caspersen C. Wang N. Yao J. Sosunov A. Chen X. Lustbader J. W. Xu H. W. Stern D. McKhann G. Yan S. D. 2005 Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040 2041.
25. Castegna A. Thongboonkerd V. Klein J. Lynn B. C. Wang Y. L. Osaka H. Wada K. Butterfield D. A. 2004 Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. J. Neurochem. 88, 1540 1546.
26. Chang E. F. Claus C. P. Vreman H. J. Wong R. J. Noble-Haeusslein L. J. 2005 Heme regulation in traumatic brain injury: relevance to the adult and developing brain. J. Cereb. Blood Flow Metab. 25, 1401 1417.
27. Chavko M. Auker C. R. McCarron R. M. 2003 Relationship between protein nitration and oxidation and development of hyperoxic seizures. Nitric Oxide 9, 18 23.
28. Chiu D. T. van den Berg J. Kuypers F. A. Hung I. J. Wei J. S. Liu T. Z. 1996 Correlation of membrane lipid peroxidation with oxidation of hemoglobin variants: possibly related to the rates of hemin release. Free Radic. Biol. Med. 21, 89 95.
29. Choi J. Levey A. I. Weintraub S. T. Rees H. D. Gearing M. Chin L. S. Li L. 2004 Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279, 13 256 13 264.
30. Ciechanover A. Brundin P. 2003 The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427 446.
31. Davies M. J. 2005 The oxidative environment and protein damage. Biochim. Biophys. Acta 1703, 93 109.
32. Davies S. S. Amarnath V. Montine K. S. Bernoud-Hubac N. Boutaud O. Montine T. J. Roberts L. J. II. 2002 Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. FASEB J. 16, 715 717.
33. Decker E. A. Livisay S. A. Zhou S. 2000 A re-evaluation of the antioxidant activity of purified carnosine. Biochemistry (Mosc.) 65, 766 770.
34. Demasi M. Davies K. J. 2003 Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism. FEBS Lett. 542, 89 94.
35. Ding Q. Dimayuga E. Markesbery W. R. Keller J. N. 2004 Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures. J. Neurochem. 91, 1211 1218.
36. Dringen R. Pawlowski P. G. Hirrlinger J. 2005 Peroxide detoxification by brain cells. J. Neurosci. Res. 79, 157 165.
37. Duncan A. J. Heales S. J. 2005 Nitric oxide and neurological disorders. Mol. Aspects Med. 26, 67 96.
38. Eckert G. P. Wood W. G. Muller W. E. 2005 Statins: drugs for Alzheimer's disease? J. Neural Transm. 112, 1057 1071.
39. El-Khamisy S. F. Saifi G. M. Weinfeld M. Johansson F. Helleday T. Lupski J. R. Caldecott K. W. 2005 Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434, 108 113.
40. Englander E. W. Ma H. 2006 Differential modulation of base excision repair activities during brain ontogeny: implications for repair of transcribed DNA. Mech. Ageing Dev. 127, 64 69.
41. Esterbauer H. Schaur R. J. Zollner H. 1991 Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81 128.
42. Evans M. D. Dizdaroglu M. Cooke M. S. 2004 Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 567, 1 61.
43. Ezaki J. Kominami E. 2004 The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol. 14, 77 85.
44. Fam S. S. Morrow J. D. 2003 The isoprostanes: unique products of arachidonic acid oxidation - a review. Curr. Med. Chem. 10, 1723 1740.
45. Farooqui A. A. Ong W. Y. Lu X. R. Halliwell B. Horrocks L. A. 2001 Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res. Brain Res. Rev. 38, 61 78.
46. Fonfria E. Marshall I. C. Boyfield I. Skaper S. D. Hughes J. P. Owen D. E. Zhang W. Miller B. A. Benham C. D. McNulty S. 2005 Amyloid β-peptide (1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J. Neurochem. 95, 715 723.
47. Foote C. S. Shook F. C. Abakerli R. B. 1984 Characterization of singlet oxygen. Methods Enzymol. 105, 36 47.
48. Fridovich I. 1989 Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 264, 7761 7764.
49. Fridovich I. 1995 Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64, 97 112.
50. Fridovich I. 1999 Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann. N. Y. Acad. Sci. 893, 13 18.
51. Gal S. Zheng H. Fridkin M. Youdim M. B. 2005 Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. J. Neurochem. 95, 79 88.
52. Georgiou G. Masip L. 2003 Biochemistry. An overoxidation journey with a return ticket. Science 300, 592 594.
53. Girotti A. W. Kriska T. 2004 Role of lipid hydroperoxides in photo-oxidative stress signaling. Antioxid. Redox Signal. 6, 301 310.
54. Gonzalez F. J. 2005 Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 569, 101 110.
55. Gonzalez-Zulueta M. Ensz L. M. Mukhina G. Lebovitz R. M. Zwacka R. M. Engelhardt J. F. Oberley L. W. Dawson V. L. Dawson T. M. 1998 Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18, 2040 2055.
56. Green P. S. Mendez A. J. Jacob J. S. Crowley J. R. Growdon W. Hyman B. T. Heinecke J. W. 2004 Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J. Neurochem. 90, 724 733.
57. Greenacre S. A. Ischiropoulos H. 2001 Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res. 34, 541 581.
58. Grune T. Davies K. J. 2003 The proteasomal system and HNE-modified proteins. Mol. Aspects Med. 24, 195 204.
59. Grune T. Merker K. Sandig G. Davies K. J. 2003 Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem. Biophys. Res. Commun. 305, 709 718.
60. Grune T. Jung T. Merker K. Davies K. J. 2004 Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 36, 2519 2530.
61. Guarente L. 2005 Calorie restriction and SIR2 genes - towards a mechanism. Mech. Ageing Dev. 126, 923 928.
62. Gutteridge J. M. 1983 Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett. 157, 37 40.
63. Gutteridge J. M. 1986 Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201, 291 295.
64. Gutteridge J. M. 1992 Iron and oxygen radicals in brain. Ann. Neurol. 32, S16 S21.
65. Gutteridge J. M. Smith A. 1988 Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem. J. 256, 861 865.
66. Halliwell B. 1984 Manganese ions, oxidation reactions and the superoxide radical. Neurotoxicology 5, 113 117.
67. Halliwell B. 1992 Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609 1623.
68. Halliwell B. 2001 Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685 716.
69. Halliwell B. 2002 Hypothesis: proteasomal dysfunction: a primary event in neurodegeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. N. Y. Acad. Sci. 962, 182 194.
70. Halliwell B. 2003 Oxidative stress in cell culture: an under-appreciated problem? FEBS Lett. 540, 3 6.
71. Halliwell B. 2006 Proteasomal dysfunction: a common feature of all neurodegenerative diseases? Implications for the environmental origins of neurodegeneration. Antiox. Redox Signal in press :.
72. Halliwell B. Gutteridge J. M. 1984 Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219, 1 14.
73. Halliwell B. Gutteridge J. M. 1990 Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186, 1 85.
74. Halliwell B. Gutteridge J. M. 1992 Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett. 307, 108 112.
75. Halliwell B. Gutteridge J. M. 1997 Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J. Neurochem. 69, 1330 1331.
76. Halliwell B. Gutteridge J. M. C. 2006 Free Radicals in Biology and Medicine, 4th edn, Oxford University Press, Oxford.
77. Halliwell B. Whiteman M. 2004 Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142, 231 255.
78. Halliwell B. Zhao K. Whiteman M. 1999 Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res. 31, 651 669.
79. Halliwell B. Rafter J. Jenner A. 2005 Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 81, 268S 276S.
80. Hart P. E. Lodi R. Rajagopalan B. et al. 2005 Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch. Neurol. 62, 621 626.
81. Hayton S. M. Muller D. P. 2004 Vitamin E in neural and visual function. Ann. N. Y. Acad. Sci. 1031, 263 270.
82. Herold S. Fago A. Weber R. E. Dewilde S. Moens L. 2004 Reactivity studies of the Fe(III) and Fe(II) NO forms of human neuroglobin reveal a potential role against oxidative stress. J. Biol. Chem. 279, 22 841 22 847.
83. Higgins J. J. Pucilowska J. Lombardi R. Q. Rooney J. P. 2004 A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 63, 1927 1931.
84. Hinerfeld D. Traini M. D. Weinberger R. P. Cochran B. Doctrow S. R. Harry J. Melov S. 2004 Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J. Neurochem. 88, 657 667.
85. Hou X. Roberts L. J. II., Gobeil F. Jr. et al. 2004 Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculature. Free Radic. Biol. Med. 36, 163 172.
86. Hovatta I. Tennant R. S. Helton R. et al. 2005 Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438, 662 666.
87. Howard L. A. Miksys S. Hoffmann E. Mash D. Tyndale R. F. 2003 Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br. J. Pharmacol. 138, 1376 1386.
88. Huang J. Agus D. B. Winfree C. J. et al. 2001 Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc. Natl Acad. Sci. USA 98, 11 720 11 724.
89. Imlay J. A. 2003 Pathways of oxidative damage. Annu. Rev. Microbiol. 57, 395 418.
90. Ischiropoulos H. Beckman J. S. 2003 Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111, 163 169.
91. Jenner P. 2003 Oxidative stress in Parkinson's disease. Ann. Neurol. 53, S26 S36.
92. Jeong S. Y. David S. 2003 Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27 144 27 148.
93. Jones S. Batchelor M. Bhelt D. Clarke A. R. Collinge J. Jackson G. S. 2005 Recombinant prion protein does not possess SOD-1 activity. Biochem. J. 392, 309 312.
94. Kasai H. 2002 Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis. Free Radic. Biol. Med. 33, 450 456.
95. Keller J. N. Huang F. F. Dimayuga E. R. Maragos W. F. 2000 Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic. Biol. Med. 29, 1037 1042.
96. Keller J. N. Dimayuga E. Chen Q. Thorpe J. Gee J. Ding Q. 2004 Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int. J. Biochem. Cell Biol. 36, 2376 2391.
97. Keller J. N. Schmitt F. A. Scheff S. W. Ding Q. Chen Q. Butterfield D. A. Markesbery W. R. 2005 Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152 1156.
98. Kim G. W. Gasche Y. Grzeschik S. Copin J. C. Maier C. M. Chan P. H. 2003 Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? J. Neurosci. 23, 8733 8742.
99. Kirkwood T. B. 2005 Understanding the odd science of aging. Cell 120, 437 447.
100. Klotz L. O. Sies H. 2003 Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol. Lett. 140-141, 125 132.
101. Koh D. W. Dawson T. M. Dawson V. L. 2005 Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol. Res. 52, 5 14.
102. Kondo M. Shibata T. Kumagai T. Osawa T. Shibata N. Kobayashi M. Sasaki S. Iwata M. Noguchi N. Uchida K. 2002 15-Deoxy-delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. Proc. Natl Acad. Sci. USA 99, 7367 7372.
103. Krause K. H. 2004 Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J. Infect. Dis. 57, S28 S29.
104. Krizbai I. A. Bauer H. Bresgen N. Eckl P. M. Farkas A. Szatmari E. Traweger A. Wejksza K. Bauer H. C. 2005 Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell. Mol. Neurobiol. 25, 129 139.
105. Kruman I. I. 2004 Why do neurons enter the cell cycle? Cell Cycle 3, 769 773.
106. Kruman I. I. Schwartz E. Kruman Y. Cutler R. G. Zhu X. Greig N. H. Mattson M. P. 2004 Suppression of uracil-DNA glycosylase induces neuronal apoptosis. J. Biol. Chem. 279, 43 952 43 960.
107. Kudin A. P. Debska-Vielhaber G. Kunz W. S. 2005 Characterization of superoxide production sites in isolated rat brain and skeletal muscle mitochondria. Biomed. Pharmacother. 59, 163 168.
108. Lebovitz R. M. Zhang H. Vogel H. Cartwright J. Jr., Dionne L. Lu N. Huang S. Matzuk M. M. 1996 Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl Acad. Sci. USA 93, 9782 9787.
109. Lee M. H. Hyun D. H. Jenner P. Halliwell B. 2001 Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 32 41.
110. Leung I. Tso M. Li W. Lam T. 2001 Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract. Invest. Ophthalmol. Vis. Sci. 42, 466 471.
111. Liang L. P. Patel M. 2004 Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease. J. Neurochem. 90, 1076 1084.
112. Lin S. Wei X. Bales K. R. Paul A. B. Ma Z. Yan G. Paul S. M. Du Y. 2005 Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia- induced cerebellar hypoplasia in the Gunn rat. Eur. J. Neurosci. 22, 21 27.
113. Linder N. Rapola J. Raivio K. O. 1999 Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab. Invest. 79, 967 974.
114. Liochev S. I. Fridovich I. 2005 Cross-compartment protection by SOD1. Free Radic. Biol. Med. 38, 146 147.
115. Mailly F. Marin P. Israel M. Glowinski J. Premont J. 1999 Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis. J. Neurochem. 73, 1181 1188.
116. Mandel S. A. Avramovich-Tirosh Y. Reznichenko L. Zheng H. Weinreb O. Amit T. Youdim M. B. 2005 Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14, 46 60.
117. Maples K. R. Ma F. Zhang Y. K. 2001 Comparison of the radical trapping ability of PBN, S-PPBN and NXY-059. Free Radic. Res. 34, 417 426.
118. Maples K. R. Green A. R. Floyd R. A. 2004 Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke. CNS Drugs 18, 1071 1084.
119. Marchis S. D. Modena C. Peretto P. Migheli A. Margolis F. L. Fasolo A. 2000 Carnosine-related dipeptides in neurons and glia. Biochemistry (Mosc.) 65, 824 833.
120. Margaill I. Plotkine M. Lerouet D. 2005 Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39, 429 443.
121. Mark R. J. Lovell M. A. Markesbery W. R. Uchida K. Mattson M. P. 1997 A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255 264.
122. Markesbery W. R. Kryscio R. J. Lovell M. A. Morrow J. D. 2005 Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann. Neurol. 58, 730 735.
123. Martin C. J. 2006 Manganese neurotoxicity: Connecting the dots along the continuum of dysfunction. Neurotoxicology in press :.
124. Martin A. Youdim K. Szprengiel A. Shukitt-Hale B. Joseph J. 2002 Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. Nutr. Rev. 60, 308 326.
125. Marx J. 2005 Neuroscience. Preventing Alzheimer's: a lifelong commitment? Science 309, 864 866.
126. Mattson M. P. Chan S. L. 2003 Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34, 385 397.
127. Mattson M. P. Duan W. Wan R. Guo Z. 2004 Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. Neurorx 1, 111 116.
128. McDonald S. R. Sohal R. S. Forster M. J. 2005 Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice. Free Radic. Biol. Med. 38, 729 736.
129. McNaught K. S. Olanow C. W. Halliwell B. Isacson O. Jenner P. 2001 Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2, 589 594.
130. Melov S. Schneider J. A. Day B. J. Hinerfeld D. Coskun P. Mirra S. S. Crapo J. D. Wallace D. C. 1998 A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18, 159 163.
131. Miksys S. Tyndale R. F. 2004 The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab. Rev. 36, 313 333.
132. Miksys S. Rao Y. Hoffmann E. Mash D. C. Tyndale R. F. 2002 Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J. Neurochem. 82, 1376 1387.
133. Mitsiades C. S. Mitsiades N. Hideshima T. Richardson P. G. Anderson K. C. 2005 Proteasome inhibitors as therapeutics. Essays Biochem. 41, 205 218.
134. Miyajima H. 2003 Aceruloplasminemia, an iron metabolic disorder. Neuropathology 23, 345 350.
135. Miyamoto S. Martinez G. R. Medeiros M. H. Di Mascio P. 2003 Singlet molecular oxygen generated from lipid hydroperoxides by the Russell mechanism: studies using 18(O)-labeled linoleic acid hydroperoxide and monomol light emission measurements. J. Am. Chem. Soc. 125, 6172 6179.
136. Moore D. J. West A. B. Dawson V. L. Dawson T. M. 2005 Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57 87.
137. Moosmann B. Behl C. 2002 Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Invest. Drugs 11, 1407 1435.
138. Moreira P. I. Honda K. Liu Q. Santos M. S. Oliveira C. R. Aliev G. Nunomura A. Zhu X. Smith M. A. Perry G. 2005 Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr. Alzheimer Res. 2, 403 408.
139. Morrow J. D. 2005 Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25, 279 286.
140. Moskovitz J. Stadtman E. R. 2003 Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues. Proc. Natl Acad. Sci. USA 100, 7486 7490.
141. Muller D. P. Goss-Sampson M. A. 1990 Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Crit. Rev. Neurobiol. 5, 239 263.
142. Musiek E. S. Milne G. L. McLaughlin B. Morrow J. D. 2005 Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol. 15, 149 158.
143. Nigam S. Schewe T. 2000 Phospholipase A(2)s and lipid peroxidation. Biochim. Biophys. Acta 1488, 167 181.
144. Nimmerjahn A. Kirchhoff F. Helmchen F. 2005 Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314 1318.
145. Olanow C. W. 2004 The scientific basis for the current treatment of Parkinson's disease. Annu. Rev. Med. 55, 41 60.
146. Ong W. Y. Halliwell B. 2004 Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann. N. Y. Acad. Sci. 1012, 51 64.
147. Ong W. Y. Hu C. Y. Hjelle O. P. Ottersen O. P. Halliwell B. 2000a Changes in glutathione in the hippocampus of rats injected with kainate: depletion in neurons and upregulation in glia. Exp. Brain Res. 132, 510 516.
148. Ong W. Y. Lu X. R. Hu C. Y. Halliwell B. 2000b Distribution of hydroxynonenal-modified proteins in the kainate-lesioned rat hippocampus: evidence that hydroxynonenal formation precedes neuronal cell death. Free Radic. Biol. Med. 28, 1214 1221.
149. Orr H. T. 2004 Neurodegenerative disease: neuron protection agency. Nature 431, 747 748.
150. Orrell R. W. Lane R. J. Ross M. 2005 Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev., CD002829.
151. Parks E. Traber M. G. 2000 Mechanisms of vitamin E regulation: research over the past decade and focus on the future. Antioxid. Redox Signal. 2, 405 412.
152. Passage E. Norreel J. C. Noack-Fraissignes P. Sanguedolce V. Pizant J. Thirion X. Robaglia-Schlupp A. Pellissier J. F. Fontes M. 2004 Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10, 396 401.
153. Patenaude A. Murthy M. R. Mirault M. E. 2005 Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell. Mol. Life Sci. 62, 1063 1080.
154. Paul T. 2000 Effect of a prolonged superoxide flux on transferrin and ferritin. Arch. Biochem. Biophys. 382, 253 261.
155. Phillis J. W. O'Regan M. H. 2004 A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res. Brain Res. Rev. 44, 13 47.
156. Phumala N. Porasuphatana S. Unchern S. Pootrakul P. Fucharoen S. Chantharaksri U. 2003 Hemin: a possible cause of oxidative stress in blood circulation of beta-thalassemia/hemoglobin E disease. Free Radic. Res. 37, 129 135.
157. Porciuncula L. O. Rocha J. B. Cimarosti H. Vinade L. Ghisleni G. Salbego C. G. Souza D. O. 2003 Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen-glucose deprivation: correlation with immunocontent of inducible nitric oxide synthase. Neurosci. Lett. 346, 101 104.
158. Pratico D. Uryu K. Leight S. Trojanoswki J. Q. Lee V. M. 2001 Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183 4187.
159. Przedborski S. Ischiropoulos H. 2005 Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid. Redox Signal. 7, 685 693.
160. Puppo A. Halliwell B. 1988 Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent? Biochem. J. 249, 185 190.
161. Pyne-Geithman G. J. Morgan C. J. Wagner K. Dulaney E. M. Carrozzella J. Kanter D. S. Zuccarello M. Clark J. F. 2005 Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 25, 1070 1077.
162. Rao R. V. Niazi K. Mollahan P. Mao X. Crippen D. Poksay K. S. Chen S. Bredesen D. E. 2006 Coupling endoplasmic reticulum stress to the cell-death program: a novel HSP90-independent role for the small chaperone protein p23. Cell Death Differ. 13, 415 425.
163. Reddy P. H. Beal M. F. 2005 Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain. Res. Rev. 49, 618 632.
164. Rhee S. G. Chae H. Z. Kim K. 2005 Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543 1552.
165. Rice M. E. 2000 Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23, 209 216.
166. Rice-Evans C. Okunade G. Khan R. 1989 The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine. Free Radic. Res. Commun. 7, 45 54.
167. Roy S. Lado B. H. Khanna S. Sen C. K. 2002 Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett. 530, 17 23.
168. Rustin P. Bonnet D. Rotig A. Munnich A. Sidi D. 2004 Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology 62, 524 525.
169. Salerno-Kennedy R. Cashman K. D. 2005 Relationship between dementia and nutrition-related factors and disorders: an overview. Int. J. Vitam. Nutr. Res. 75, 83 95.
170. Salomon R. G. 2005 Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways. Chem. Phys. Lipids 134, 1 20.
171. Sanchez-Carbente M. R. Castro-Obregon S. Covarrubias L. Narvaez V. 2005 Motoneuronal death during spinal cord development is mediated by oxidative stress. Cell Death Differ. 12, 279 291.
172. Savaraj N. Wei Y. Unate H. Liu P. M. Wu C. J. Wangpaichitr M. Xia D. Xu H. J. Hu S. X. Tien Kuo M. 2005 Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radic. Res. 39, 373 381.
173. Schenck J. F. Zimmerman E. A. 2004 High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed. 17, 433 445.
174. Schulz J. B. Dehmer T. Schols L. et al. 2000 Oxidative stress in patients with Friedreich ataxia. Neurology 55, 1719 1721.
175. Serbinova E. Choo M. Packer L. 1992 Distribution and antioxidant activity of a palm oil carotene fraction in rats. Biochem. Int. 28, 881 886.
176. Sheu K. F. Blass J. P. 1999 The alpha-ketoglutarate dehydrogenase complex. Ann. N. Y. Acad. Sci. 893, 61 78.
177. Sinet P. M. Heikkila R. E. Cohen G. 1980 Hydrogen peroxide production by rat brain in vivo. J. Neurochem. 34, 1421 1428.
178. Smith K. S. Smith P. L. Heady T. N. Trugman J. M. Harman W. D. Macdonald T. L. 2003 In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity. Chem. Res. Toxicol. 16, 123 128.
179. Smith W. L. 2005 Cyclooxygenases, peroxide tone and the allure of fish oil. Curr. Opin. Cell Biol. 17, 174 182.
180. Sotiriou S. Gispert S. Cheng J. et al. 2002 Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med. 8, 514 517.
181. Spencer J. P. Jenner P. Daniel S. E. Lees A. J. Marsden D. C. Halliwell B. 1998 Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71, 2112 2122.
182. Spencer J. P. Abd-el-Mohsen M. M. Rice-Evans C. 2004 Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch. Biochem. Biophys. 423, 148 161.
183. Stahl W. Schwarz W. Sundquist A. R. Sies H. 1992 Cis-trans isomers of lycopene and beta-carotene in human serum and tissues. Arch. Biochem. Biophys. 294, 173 177.
184. Stefanis L. Keller J. N. 2006 The Proteasome in Neurodegeneration. Springer, New York.
185. Sullivan P. G. Dragicevic N. B. Deng J. H. Bai Y. Dimayuga E. Ding Q. Chen Q. Bruce-Keller A. J. Keller J. N. 2004 Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279, 20 699 20 707.
186. Sultana R. Perluigi M. Butterfield D. A. 2006 Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta (1-42). J. Chromatogr. B. 833, 3 11.
187. Sung S. Yao Y. Uryu K. Yang H. Lee V. M. Trojanowski J. Q. Pratico D. 2004 Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 18, 323 325.
188. Swain J. A. Darley-Usmar V. Gutteridge J. M. 1994 Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342, 49 52.
189. Swanson R. A. Ying W. Kauppinen T. M. 2004 Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4, 193 205.
190. Tang S. Y. Whiteman M. Jenner A. Peng Z. F. Halliwell B. 2004 Mechanism
191. Turrens J. F. 2003 Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335 344.
192. Valentine W. M. Hill K. E. Austin L. M. Valentine H. L. Goldowitz D. Burk R. F. 2005 Brainstem axonal degeneration in mice with deletion of selenoprotein P. Toxicol. Pathol. 33, 570 576.
193. Van Bergen P. Rauhala P. Spooner C. M. Chiueh C. C. 1999 Hemoglobin and iron-evoked oxidative stress in the brain: protection by bile pigments, manganese and S-nitrosoglutathione. Free Radic. Res. 31, 631 640.
194. Van Maldergem L. Trijbels F. DiMauro S. Sindelar P. J. Musumeci O. Janssen A. Delberghe X. Martin J. J. Gillerot Y. 2002 Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann. Neurol. 52, 750 754.
195. Van Remmen H. Ikeno Y. Hamilton M. et al. 2003 Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 16, 29 37.
196. Vatassery G. T. Adityanjee Quach H. T. Smith W. E. Kuskowski M. A. Melnyk D. 2004 α and γ tocopherols in cerebrospinal fluid and serum from older, male, human subjects. J. Am. Coll. Nutr. 23, 233 238.
197. Velliquette R. A. O'Connor T. Vassar R. 2005 Energy inhibition elevates β-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci. 25, 10874 10883.
198. Walther M. Holzhutter H. G. Kuban R. J. Wiesner R. Rathmann J. Kuhn H. 1999 The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere. Mol. Pharmacol. 56, 196 203.
199. Watanabe C. M. Wolffram S. Ader P. Rimbach G. Packer L. Maguire J. J. Schultz P. G. Gohil K. 2001 The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc. Natl Acad. Sci. USA 98, 6577 6580.
200. Wentworth P. Jr., Nieva J. Takeuchi C. et al. 2003 Evidence for ozone formation in human atherosclerotic arteries. Science 302, 1053 1056.
201. Whittier J. E. Xiong Y. Rechsteiner M. C. Squier T. C. 2004 Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome. J. Biol. Chem. 279, 46 135 46 142.
202. Wrona M. Z. Dryhurst G. 1998 Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders. Chem. Res. Toxicol. 11, 639 650.
203. Yan S. D. Stern D. M. 2005 Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-β peptide alcohol dehydrogenase (ABAD). Int. J. Exp. Pathol. 86, 161 171.
204. Yew E. H. Cheung N. S. Choy M. S. et al. 2005 Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis. J. Neurochem. 94, 943 956.
205. Zbarsky V. Datla K. P. Parkar S. Rai D. K. Aruoma O. I. Dexter D. T. 2005 Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 39, 1119 1125.
206. Zecca L. Youdim M. B. Riederer P. Connor J. R. Crichton R. R. 2004 Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863 873.
207. Zeevalk G. D. Bernard L. P. Song C. Gluck M. Ehrhart J. 2005 Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration. Antioxid. Redox Signal. 7, 1117 1139.
208. Zhang X. Xie W. Qu S. Pan T. Wang X. Le W. 2005 Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. Biochem. Biophys. Res. Commun. 333, 544 549.
209. Zhou B. Westaway S. K. Levinson B. Johnson M. A. Gitschier J. Hayflick S. J. 2001 A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28, 345 349.
210. Zingg J. M. Azzi A. 2004 Non-antioxidant activities of vitamin E. Curr. Med. Chem. 11, 1113 1133.
211. del Zoppo G. P. 2006 Stroke and neurovascular protection. N. Engl. J. Med. 354, 553 555.